142 related articles for article (PubMed ID: 12500971)
1. Structural determinants of the calpain inhibitory activity of calpastatin peptide B27-WT.
Betts R; Weinsheimer S; Blouse GE; Anagli J
J Biol Chem; 2003 Mar; 278(10):7800-9. PubMed ID: 12500971
[TBL] [Abstract][Full Text] [Related]
2. The beta- and gamma-CH2 of B27-WT's Leu11 and Ile18 side chains play a direct role in calpain inhibition.
Betts R; Anagli J
Biochemistry; 2004 Mar; 43(9):2596-604. PubMed ID: 14992597
[TBL] [Abstract][Full Text] [Related]
3. Amino-terminal conserved region in proteinase inhibitor domain of calpastatin potentiates its calpain inhibitory activity by interacting with calmodulin-like domain of the proteinase.
Ma H; Yang HQ; Takano E; Hatanaka M; Maki M
J Biol Chem; 1994 Sep; 269(39):24430-6. PubMed ID: 7929105
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling studies of peptide inhibitors highlight the importance of conformational prearrangement for inhibition of calpain.
Jiao W; McDonald DQ; Coxon JM; Parker EJ
Biochemistry; 2010 Jul; 49(26):5533-9. PubMed ID: 20499928
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human mu-calpain by conformationally constrained calpastatin peptides.
Pfizer J; Assfalg-Machleidt I; Machleidt W; Schaschke N
Biol Chem; 2008 Jan; 389(1):83-90. PubMed ID: 18095873
[TBL] [Abstract][Full Text] [Related]
6. A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor.
Todd B; Moore D; Deivanayagam CC; Lin GD; Chattopadhyay D; Maki M; Wang KK; Narayana SV
J Mol Biol; 2003 Apr; 328(1):131-46. PubMed ID: 12684003
[TBL] [Abstract][Full Text] [Related]
7. Detecting the active conformation of calpain with calpastatin-based reagents.
Croall DE; Vanhooser LM; Cashon RE
Biochim Biophys Acta; 2008 Nov; 1784(11):1676-86. PubMed ID: 18793761
[TBL] [Abstract][Full Text] [Related]
8. Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin.
Gil-Parrado S; Assfalg-Machleidt I; Fiorino F; Deluca D; Pfeiler D; Schaschke N; Moroder L; Machleidt W
Biol Chem; 2003 Mar; 384(3):395-402. PubMed ID: 12715890
[TBL] [Abstract][Full Text] [Related]
9. Structure of the active 27-residue fragment of human calpastatin.
Ishima R; Tamura A; Akasaka K; Hamaguchi K; Makino K; Murachi T; Hatanaka M; Maki M
FEBS Lett; 1991 Dec; 294(1-2):64-6. PubMed ID: 1743294
[TBL] [Abstract][Full Text] [Related]
10. Formation of the calpain-1/calpastatin complex promotes activation of calpain-1 under oxidizing conditions.
Maddock Carlin KR; Steadham E; Huff-Lonergan E; Lonergan SM
J Anim Sci; 2024 Jan; 102():. PubMed ID: 38738874
[TBL] [Abstract][Full Text] [Related]
11. Analysis of structure-function relationship of pig calpastatin by expression of mutated cDNAs in Escherichia coli.
Maki M; Takano E; Osawa T; Ooi T; Murachi T; Hatanaka M
J Biol Chem; 1988 Jul; 263(21):10254-61. PubMed ID: 2839481
[TBL] [Abstract][Full Text] [Related]
12. Local structural preferences of calpastatin, the intrinsically unstructured protein inhibitor of calpain.
Kiss R; Kovács D; Tompa P; Perczel A
Biochemistry; 2008 Jul; 47(26):6936-45. PubMed ID: 18537264
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene.
Maki M; Bagci H; Hamaguchi K; Ueda M; Murachi T; Hatanaka M
J Biol Chem; 1989 Nov; 264(32):18866-9. PubMed ID: 2553724
[TBL] [Abstract][Full Text] [Related]
14. Calpastatin has two distinct sites for interaction with calpain--effect of calpastatin fragments on the binding of calpain to membranes.
Kawasaki H; Emori Y; Suzuki K
Arch Biochem Biophys; 1993 Sep; 305(2):467-72. PubMed ID: 8373185
[TBL] [Abstract][Full Text] [Related]
15. [Calpain and calpastatin].
Murachi T
Rinsho Byori; 1990 Apr; 38(4):337-46. PubMed ID: 2195187
[TBL] [Abstract][Full Text] [Related]
16. Requirement of different subdomains of calpastatin for calpain inhibition and for binding to calmodulin-like domains.
Ma H; Yang HQ; Takano E; Lee WJ; Hatanaka M; Maki M
J Biochem; 1993 May; 113(5):591-9. PubMed ID: 8340353
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic processing of human profilaggrin by active mu-calpain.
Yamazaki M; Ishidoh K; Suga Y; Saido TC; Kawashima S; Suzuki K; Kominami E; Ogawa H
Biochem Biophys Res Commun; 1997 Jun; 235(3):652-6. PubMed ID: 9207214
[TBL] [Abstract][Full Text] [Related]
18. The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion.
Barnoy S; Glasner T; Kosower NS
Biochem Biophys Res Commun; 1996 Mar; 220(3):933-8. PubMed ID: 8607870
[TBL] [Abstract][Full Text] [Related]
19. Studies of the active site of m-calpain and the interaction with calpastatin.
Crawford C; Brown NR; Willis AC
Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):135-42. PubMed ID: 8250833
[TBL] [Abstract][Full Text] [Related]
20. Calpain and calpastatin in myoblast differentiation and fusion: effects of inhibitors.
Barnoy S; Glaser T; Kosower NS
Biochim Biophys Acta; 1997 Sep; 1358(2):181-8. PubMed ID: 9332454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
